rel-Benzyl (3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

2304514-60-9rel-Benzyl (3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate

● 재고 있음

카탈로그 번호:VE0024621
CAS 번호:2304514-60-9
분자식:C16H20BrNO3
분자량:354.24 g/mol

에 대한 추가 정보 CAS 2304514-60-9

모약물

Upadacitinib

IUPAC명

rel-Benzyl (3R, 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate

약전 동의어

N/A

Other Synonyms

Benzyl (3R, 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate, rel-; Benzyl (3R, 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate

SMILES

O=C(N1C[C@H](C(CBr)=O)[C@@H](CC)C1)OCC2=CC=CC=C2

InChI

InChI=1S/C16H20BrNO3/c1-2-13-9-18(10-14(13)15(19)8-17)16(20)21-11-12-6-4-3-5-7-12/h3-7, 13-14H, 2, 8-11H2, 1H3/t13-, 14-/m0/s1

설명

rel-Benzyl (3R | 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate is a well-characterized reference material that meets stringent regulatory standards set by USP | EMA | JP | and BP. It plays a key role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial production of Upadacitinib.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url